KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2025)

Historic FCF Margin for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to 8.02%.

  • Adaptive Biotechnologies' FCF Margin rose 510100.0% to 8.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.9%, marking a year-over-year increase of 397100.0%. This contributed to the annual value of 55.25% for FY2024, which is 428400.0% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its FCF Margin stood at 8.02% for Q3 2025, which was up 510100.0% from 22.22% recorded in Q2 2025.
  • Adaptive Biotechnologies' FCF Margin's 5-year high stood at 8.02% during Q3 2025, with a 5-year trough of 353.94% in Q2 2023.
  • Moreover, its 5-year median value for FCF Margin was 100.02% (2022), whereas its average is 112.45%.
  • As far as peak fluctuations go, Adaptive Biotechnologies' FCF Margin plummeted by -2340000bps in 2023, and later surged by 3098700bps in 2024.
  • Over the past 5 years, Adaptive Biotechnologies' FCF Margin (Quarter) stood at 166.28% in 2021, then surged by 65bps to 58.99% in 2022, then decreased by -5bps to 61.66% in 2023, then surged by 57bps to 26.49% in 2024, then soared by 70bps to 8.02% in 2025.
  • Its last three reported values are 8.02% in Q3 2025, 22.22% for Q2 2025, and 56.71% during Q1 2025.